Sandoz Follows US Denosumab Filing With European Acceptance

Dual Filings With EMA For Prolia/Xgeva Biosimilars Confirmed By Novartis Unit

 
• By David Wallace
  
Two jigsaw pieces with US and EU flags
Sandoz is following its US denosumab filing with an EU submission • Source: Shutterstock

More from Biosimilars

More from Products